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Immunization against pertussis was introduced in China in the
1960s. Since the 1970s, no culture-confirmed pertussis cases
have been reported in the country. We report six infants with
culture-confirmed pertussis, who were initially diagnosed as
having other respiratory diseases, at Beijing Children’s Hospi-
tal, Beijing.
mmunization against pertussis was begun in China in the
1960s. Three doses of whole cell pertussis vaccine com-
bined with diphtheria and tetanus toxoids are given at 3, 4, and
5 months of age (1). Since 1982, a booster dose has been
added, given at 18–24 months of age (1).
In the 1990s, >85% of children received at least three
doses of vaccine, and the incidence of pertussis (based on clin-
ical diagnosis) remained <1/100,000 population (1). In China,
pertussis is a reportable infectious disease, diagnosed by phy-
sicians. Since the 1970s, no culture-confirmed pertussis cases
have been reported in the country. However, during April–
June 1997, a local outbreak of pertussis was reported in a rural
village (population 1,387) in southwestern China (2). A total
of 285 cases were diagnosed. The ages of these patients ranged
from 6 months to 80 years; 44% were <7 years of age; and
23% were 15 years of age. No deaths were reported. The sug-
gested cause for this outbreak was relatively low vaccination
coverage in the village.
The diagnosis of pertussis, especially in patients with atyp-
ical symptoms, requires clinicians’ awareness and laboratory
tools. To our knowledge, the current laboratory methods (e.g.,
culture, enzyme immunoassay serologic testing, and poly-
merase chain reaction assay [PCR]) are not being used to diag-
nose pertussis in China. In this study, we report six cases of
culture-confirmed pertussis in infants seen at Beijing Chil-
dren’s Hospital. All six patients were initially diagnosed as
having other respiratory diseases.
The Study
To determine how much bacterial culturing would aid the
diagnosis of pertussis in China, a study was conducted in a 35-
bed ward for respiratory diseases at Beijing Children’s Hospi-
tal from June 2000 to May 2001. This facility is the largest
children’s hospital in China; it has 3,000–4,000 visits daily to
its outpatient department. Nasopharyngeal (NP) swabs were
taken from children who had been admitted to the hospital
because their cough, with or without paroxysms, had persisted
for >2 weeks and was worsening. A total of 55 children (age
range 35 days to 13 years) were enrolled during the study
period. In addition, NP swabs were obtained from two children
(ages 10 weeks and 13 years) with paroxysmal cough who
were seen at the outpatient department. Information about dis-
ease history, immunization status, and cough characteristics
was obtained. Physical examination, chest X-ray, and blood
tests were performed. At admission, all participants were diag-
nosed as having bronchitis, bronchopneumonia, or pneumonia.
After collection, NP swabs were immediately spread onto
charcoal agar plates supplemented with cephalexin. Details of
Bordetella pertussis culture have been described previously
(3). In brief, after inoculation, the plates were incubated in a
humid atmosphere at 35°C and inspected daily for 7 days to
determine pertussis-like colony growth. Suspected colonies
were Gram stained and tested by slide agglutination with anti-
sera to B. pertussis and B. parapertussis (Murex Diagnostics,
Dartford, England).
Serum immunoglobulin (Ig) G antibodies to purified per-
tussis toxin (PT) were tested by enzyme immunoassay, as
described (3). Seropositivity was determined by comparing the
antibody results in patient serum samples with those in 460
healthy Chinese persons. Results exceeding the mean of the
controls by two standard deviations were considered to be
seropositive.
Conclusions
Six infants <4 months of age were culture positive for B.
pertussis (Table). Five of these patients were in the study
group of 55 hospitalized children; the other was one of two
children seen at the outpatient department. Before they went to
the hospital, all six infants had taken broad-spectrum antibiot-
ics but not erythromycin. None had received any doses of per-
tussis vaccine.
The immediate family members or other relatives of five
infants (cases 1, 2, 4, 5, and 6) had concurrent and persistent
cough (Table). NP swabs and serum samples were obtained
from family members of cases 1, 5, and 6 (data not shown).
Case-patient 1’s grandmother was culture positive for B. per-
tussis. She, as well as the patient’s mother and father, had been
coughing for several weeks, and they all had IgG diagnostic
antibodies to PT in their sera. Patient 5’s mother, aunt, and 10-
year-old cousin had diagnostic serum IgG antibodies to PT,
and another, 8-year-old cousin was culture positive.  The
grandmother of case-patient 6 had been coughing for 1 month
and had diagnostic serum IgG antibodies to PT.
Because antigenic divergence, with respect to PT and pert-
actin (PRN), has been recently found between B. pertussis
vaccine strains and circulating strains, the PRN and PT types
of eight clinical strains isolated in this study and two Chinese
vaccine strains were examined. The methods used for this
genotyping were LightCycler (Roche Applied Science, Man-
nheim, Germany) real-time PCR and fluorescence resonance
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energy transfer hybridization probes (4,5). The two vaccine
strains and seven clinical strains harbored prn1, and one clini-
cal strain contained prn2. For PT types, the vaccine strains har-
bored ptxS1B or ptxS1D, and all clinical strains had ptxS1A.
To our knowledge, this is the first report of culture-con-
firmed pertussis cases from China during the last 30 years. Of
the 55 patients hospitalized for persistent cough, 5 (9%) were
culture positive for B. pertussis. These results indicate that
pertussis is not uncommon in the Chinese population and still
causes substantial illness in infants and young children,
although the pertussis vaccination coverage for the first three
doses is >85% (1).
Immunity from immunization wanes with time; thus, older
children and adults become susceptible to pertussis (6–8). The
role of older children and adults in transmitting B. pertussis to
unvaccinated infants has been well documented. More than
80% of hospitalized infants are not the index cases in their
families (9). Our results agree with these reports. The family
members and other relatives of five infants with culture-con-
firmed pertussis started to cough first. Evidence of laboratory-
confirmed pertussis was obtained from the family members
and other relatives of three infants.
Although the most serious effects from pertussis occur in
young infants (10,11), all six ill infants in our study recovered.
Pierce et al. reported 13 critically ill infants with confirmed
pertussis, all <3 months of age (11); 4 had leukocyte counts
>100 X 109/L; all these infants died. Nine had leukocyte
counts <100 X 109/L (11). In the six ill infants in our study, the
highest leukocyte count was far lower, 37 X 109/L. However,
our six patients had taken antibiotics before consultation.
In this study, pertussis was not initially suspected in these
ill infants. None had the characteristic whoop. Pertussis at this
age group is likely to be atypical, and symptoms resemble
those of other respiratory tract infection, apnea, or cyanosis.
Consequently, the diagnosis of pertussis is not considered and
the treatment is delayed (10). These six infants were initially
diagnosed as having bronchitis, bronchopneumonia, or pneu-
monia. The fact that pertussis was not considered in the differ-
ential diagnosis may indicate that clinicians were not aware
that B. pertussis was circulating in the community.
Early and correct diagnosis of pertussis is important for
effective therapy and prevention of transmission of the dis-
ease. Culture of B. pertussis from NP samples usually takes 3–
7 days. In comparison with culture, PCR is a more sensitive
and specific method for diagnosing pertussis (3). Measurement
of specific serum antibodies to B. pertussis antigens by
enzyme immunoassay can also facilitate this diagnosis, and
results are helpful for epidemiologic studies (3,7,12). The use
of culture for the diagnosis of pertussis is now being consid-
ered in Beijing Children’s Hospital.
Our results suggest that a number of pertussis cases are
likely being misdiagnosed in China and that the incidence of
the diseases is underestimated.
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